These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38160571)

  • 1. Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK's Haematological Malignancy Research Network.
    Lamb M; Painter D; Howell D; Barrans S; Cargo C; de Tute R; Tooze R; Burton C; Patmore R; Roman E; Smith A
    Cancer Epidemiol; 2024 Feb; 88():102513. PubMed ID: 38160571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15.
    Roman E; Smith A; Appleton S; Crouch S; Kelly R; Kinsey S; Cargo C; Patmore R
    Cancer Epidemiol; 2016 Jun; 42():186-98. PubMed ID: 27090942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network.
    Smith A; Crouch S; Lax S; Li J; Painter D; Howell D; Patmore R; Jack A; Roman E
    Br J Cancer; 2015 Apr; 112(9):1575-84. PubMed ID: 25867256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006.
    Storm HH; Klint A; Tryggvadóttir L; Gislum M; Engholm G; Bray F; Hakulinen T
    Acta Oncol; 2010 Jun; 49(5):694-712. PubMed ID: 20491526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN).
    Li J; Smith A; Crouch S; Oliver S; Roman E
    Cancer Causes Control; 2016 Aug; 27(8):1019-26. PubMed ID: 27351920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
    Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
    Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network.
    Smith A; Howell D; Patmore R; Jack A; Roman E
    Br J Cancer; 2011 Nov; 105(11):1684-92. PubMed ID: 22045184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries.
    Ssenyonga N; Stiller C; Nakata K; Shalkow J; Redmond S; Bulliard JL; Girardi F; Fowler C; Marcos-Gragera R; Bonaventure A; Saint-Jacques N; Minicozzi P; De P; Rodríguez-Barranco M; Larønningen S; Di Carlo V; Mägi M; Valkov M; Seppä K; Wyn Huws D; Coleman MP; Allemani C;
    Lancet Child Adolesc Health; 2022 Jun; 6(6):409-431. PubMed ID: 35468327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study.
    Sant M; Vener C; Lillini R; Rossi S; Bonfarnuzzo S; Marcos-Gragera R; Maynadié M; Innos K; Paapsi K; Visser O; Bernasconi A; Demuru E; Di Benedetto C; Mousavi SM; Blum M; Went P; Serraino D; Bennett D; Sánchez MJ; De Angelis R;
    Lancet Oncol; 2024 Jun; 25(6):731-743. PubMed ID: 38703784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study.
    Murphy F; Kroll ME; Pirie K; Reeves G; Green J; Beral V
    Br J Cancer; 2013 Jun; 108(11):2390-8. PubMed ID: 23640394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network.
    Kane E; Howell D; Smith A; Crouch S; Burton C; Roman E; Patmore R
    Eur J Cancer; 2017 Jun; 78():53-60. PubMed ID: 28412589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study.
    Kroll ME; Murphy F; Pirie K; Reeves GK; Green J; Beral V;
    Br J Cancer; 2012 Aug; 107(5):879-87. PubMed ID: 22878373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incidence of haematological malignancies in adults in Szabolcs-Szatmár-Bereg county, Hungary, between 1983 and 2012. Analysis of data from a thirty-year period].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2013 Nov; 154(47):1858-64. PubMed ID: 24240522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registry.
    Dandoit M; Mounier M; Guy J; Petrella T; Girard S; Casasnovas RO; Martin L; Bonnetain F; Maynadié M
    Leuk Lymphoma; 2015 Apr; 56(4):1050-7. PubMed ID: 25166007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of haematological cancers in Sarawak, Malaysia (1996 to 2015).
    Kuan JW; Su AT; Wahab M; Hamdan A; Hashim J; Kiyu A; Ooi CH
    BMC Cancer; 2023 Jun; 23(1):563. PubMed ID: 37337159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
    Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
    Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2016 US lymphoid malignancy statistics by World Health Organization subtypes.
    Teras LR; DeSantis CE; Cerhan JR; Morton LM; Jemal A; Flowers CR
    CA Cancer J Clin; 2016 Nov; 66(6):443-459. PubMed ID: 27618563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.